ARCHIVES

Supreme Court Decision Means FTC Scrutiny As Costly Oncology Drugs Go Off-Patent

This article is from The Cancer Letter archive.

Vol. 39 No. 25 | June 21, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: Susan O’Brien to move to UC Irvine Health

November 14, 2014

Study: BRCA2-Negative Women Could Still Have High Risk

December 27, 2013

Americans Shouldn’t Take NIH for Granted, Healy Tells NCAB

May 24, 1991

Patients Report Clinical Trials Not Offered By Physician

June 27, 2008

UCSF AIDS, Cancer Specimen Resource Bank Funded, Renamed

November 15, 2002

ARRA Funding Announcements Listed

April 10, 2009